Serum-derived hepatitis C virus infectivity in interferon regulatory factor-7-suppressed human primary hepatocytes.

[1]  Wen-Cheng Lo,et al.  Tissue engineered cartilage using human articular chondrocytes immortalized by HPV-16 E6 and E7 genes. , 2006, Journal of biomedical materials research. Part A.

[2]  Yu-Tseung Liu,et al.  Activation of anti-hepatitis C virus responses via Toll-like receptor 7. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Lionel Larue,et al.  E-cadherin synergistically induces hepatospecific phenotype and maturation of embryonic stem cells in conjunction with hepatotrophic factors. , 2005, Biotechnology and bioengineering.

[4]  K. Hirata,et al.  Hepatocyte transplantation for total liver repopulation. , 2005, Journal of hepato-biliary-pancreatic surgery.

[5]  W. Ho,et al.  Hepatitis C virus inhibits intracellular interferon alpha expression in human hepatic cell lines , 2005, Hepatology.

[6]  T. Hawley,et al.  Bypass of Senescence, Immortalization, and Transformation of Human Hematopoietic Progenitor Cells , 2005, Stem cells.

[7]  Toshiaki Maruyama,et al.  Complete Replication of Hepatitis C Virus in Cell Culture , 2005, Science.

[8]  R. Bartenschlager,et al.  Production of infectious hepatitis C virus in tissue culture from a cloned viral genome , 2005, Nature Medicine.

[9]  D. Burton,et al.  Robust hepatitis C virus infection in vitro. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Goberdhan P Dimri,et al.  Mammary epithelial cell transformation: insights from cell culture and mouse models , 2005, Breast Cancer Research.

[11]  Hideo Negishi,et al.  IRF-7 is the master regulator of type-I interferon-dependent immune responses , 2005, Nature.

[12]  S. Akira,et al.  Inhibition of RIG-I-Dependent Signaling to the Interferon Pathway during Hepatitis C Virus Expression and Restoration of Signaling by IKKε , 2005, Journal of Virology.

[13]  S. Lemon,et al.  Regulating Intracellular Antiviral Defense and Permissiveness to Hepatitis C Virus RNA Replication through a Cellular RNA Helicase, RIG-I , 2005, Journal of Virology.

[14]  S. Lemon,et al.  Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Stanley M Lemon,et al.  Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[16]  T. Ohshima,et al.  Suppression of hepatitis C virus replicon by TGF-beta. , 2005, Virology.

[17]  B. Dutrillaux,et al.  Long-term controlled immortalization of a primate hepatic progenitor cell line after Simian virus 40 T-Antigen gene transfer , 2005, Oncogene.

[18]  Ching-Fang Chang,et al.  Immortalization without neoplastic transformation of human mesenchymal stem cells by transduction with HPV16 E6/E7 genes , 2004, International journal of cancer.

[19]  P. Killenberg,et al.  Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites. , 2004, The New England journal of medicine.

[20]  P. Marcellin,et al.  Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. , 2004, Annals of internal medicine.

[21]  K. Shimotohno,et al.  Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes , 2003, Hepatology.

[22]  M. Noguchi,et al.  Expression of HNFs and C/EBPα is correlated with immunocytochemical differentiation of cell lines derived from human hepatocellular carcinomas, hepatoblastomas and immortalized hepatocytes , 2003, Cancer science.

[23]  Stanley M. Lemon,et al.  Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease , 2003, Science.

[24]  M. Zern,et al.  Telomerase reconstitution immortalizes human fetal hepatocytes without disrupting their differentiation potential. , 2003, Gastroenterology.

[25]  Dieter Häussinger,et al.  Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. , 2002, The New England journal of medicine.

[26]  P. Génin,et al.  Regulation of virus-induced interferon-A genes. , 2002, Biochimie.

[27]  A. McCullough,et al.  Surprisingly Small Effect of Antiviral Treatment in Patients with Hepatitis C , 2002, Annals of Internal Medicine.

[28]  Kenneth Koury,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[29]  A. Heim,et al.  Characterization of human myocardial fibroblasts immortalized by HPV16 E6--E7 genes. , 2001, Experimental cell research.

[30]  T. Spencer,et al.  Isolation, immortalization, and initial characterization of uterine cell lines: An in vitro model system for the procine uterus , 2000, In Vitro Cellular & Developmental Biology - Animal.

[31]  M. Alter,et al.  Epidemiology of Hepatitis C: Geographic Differences and Temporal Trends , 2000, Seminars in liver disease.

[32]  H. Kwon,et al.  Interferon regulatory factors: the next generation. , 1999, Gene.

[33]  K. Dohi,et al.  A long-term culture of human hepatocytes which show a high growth potential and express their differentiated phenotypes. , 1999, Biochemical and biophysical research communications.

[34]  J. Little,et al.  Identification of SV40 T-antigen mutants that alter T-antigen-induced chromosome damage in human fibroblasts. , 1998, Cytometry.

[35]  H. Shirasawa,et al.  Normal Human Fibroblasts Immortalized by Introduction of Human Papillomavirus Type 16 (HPV‐16) E6‐E7 Genes , 1997, Microbiology and immunology.

[36]  M. J. Tevethia,et al.  Tumorigenicity of simian virus 40-transformed rat hepatocytes. , 1981, Cancer research.